MXP22

MXP22 is a botanical extract formulation developed by the South Korean company Mediforum, specifically designed to support liver health and address Non-Alcoholic Fatty Liver Disease (NAFLD). The product is primarily composed of extracts from *Hovenia dulcis* (Oriental Raisin Tree), a plant traditionally used in East Asian medicine for its hepatoprotective and anti-intoxicant properties. MXP22 is evaluated as a health functional food (nutraceutical) intended to reduce hepatic fat accumulation and improve liver function markers such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Clinical trials, including a randomized, double-blind, placebo-controlled study (NCT05808049), have investigated its efficacy and safety in patients with NAFLD, focusing on its ability to mitigate liver damage through antioxidant mechanisms and the modulation of lipid metabolism.

Other names

MXP22MXP-22MXP 22